![1]()
Opinion
Volunteering during the pandemic: What doctors need to know
May 8, 2020
Just as others helped me achieve my goal of volunteering, I hope I can guide those who would like to do similar work by sharing details about my experience and other information I have collected about volunteering.
News
Androgens may explain male vulnerability to COVID-19
May 8, 2020
Androgen deprivation therapy may be protective against COVID-19, a study suggests.
![1]()
News
Pandemic-related stress rising among ICU clinicians
May 7, 2020
Most survey respondents “are taking special measures to limit the potential spread of the virus to their loved ones.”
News
More guidance on inpatient management of blood glucose in COVID-19
May 7, 2020
Diabetes UK’s COVID-19 task force addresses inpatient use of subcutaneous insulin for managing hyperglycemia and ketoacidosis when IVs are unavailable.
News
Results from 11 AHA-funded COVID-19 studies expected within months
May 7, 2020
The AHA’s COVID-19 and Its Cardiovascular Impact Rapid Response Grant initiative awards $1.2 million in grants.
![1]()
News
COVID-19–associated coagulopathy
May 7, 2020
Early recognition and anticoagulation is imperative to improve clinical outcomes in COVID-19–associated coagulopathies.
![1]()
News
IV-to-oral antibiotics can benefit patients with MRSA bloodstream infection
May 7, 2020
Is sequential IV-to-oral antibiotic therapy as effective as outpatient parenteral antibiotic therapy (OPAT) in patients with MRSA BSI?
News
FDA approves dapagliflozin for low-EF heart failure
May 7, 2020
The approval based on DAPA-HF makes dapagliflozin (Farxiga) the only drug in its class to be indicated for heart failure in the absence of diabetes.
News
COVID-19 pulmonary severity ascribed to coagulation differences
May 6, 2020
Higher mortality risk among whites with severe COVID-19 infections may be linked to higher propensity for thromboembolism than Chinese patients.
News
New angiotensin studies in COVID-19 give more reassurance
May 6, 2020
A deluge of new data does not suggest harm with ACE inhibitors and angiotensin blockers in COVID-19 rates or outcomes.
